{"id":436101,"date":"2026-06-24T12:16:14","date_gmt":"2026-06-24T12:16:14","guid":{"rendered":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/?p=436101"},"modified":"2026-06-24T12:16:14","modified_gmt":"2026-06-24T12:16:14","slug":"the-competitive-signals-hiding-in-plain-sight-for-biopharma","status":"publish","type":"post","link":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/blog\/the-competitive-signals-hiding-in-plain-sight-for-biopharma\/","title":{"rendered":"\u751f\u7269\u5236\u836f\u9886\u57df\u4e2d\u9690\u85cf\u4e8e\u516c\u5f00\u4fe1\u606f\u4e2d\u7684\u7ade\u4e89\u4fe1\u53f7"},"content":{"rendered":"<p>\u7ade\u4e89\u4fe1\u53f7\u662f\u9690\u85cf\u5728\u4e34\u5e8a\u8bd5\u9a8c\u66f4\u65b0\u3001\u4e13\u5229\u7533\u8bf7\u3001\u76d1\u7ba1\u6d3b\u52a8\u548c\u8bb8\u53ef\u4ea4\u6613\u7b49\u516c\u5f00\u6570\u636e\u4e2d\u7684\u65e9\u671f\u7ebf\u7d22\uff0c\u5728\u5e02\u573a\u5b8c\u5168\u53cd\u5e94\u4e4b\u524d\u5c31\u663e\u793a\u51fa\u7ade\u4e89\u5bf9\u624b\u7684\u672a\u6765\u52a8\u5411\u3002\u5728\u5236\u836f\u884c\u4e1a\uff0c\u771f\u6b63\u7684\u6d1e\u5bdf\u529b\u6765\u81ea\u4e8e\u8fde\u63a5\u8fd9\u4e9b\u4fe1\u53f7\uff0c\u56e0\u4e3a\u5355\u4e00\u7684\u7533\u8bf7\u6216\u8bd5\u9a8c\u53d8\u66f4\u7684\u610f\u4e49\u8fdc\u4e0d\u5982\u968f\u65f6\u95f4\u5f62\u6210\u7684\u6a21\u5f0f\u91cd\u8981\u3002<\/p>\n<p>\u6bcf\u5e74\uff0c\u5236\u836f\u4e1a\u52a1\u62d3\u5c55\uff08BD\uff09\u548c\u7814\u53d1\uff08R&amp;D\uff09\u56e2\u961f\u90fd\u4f1a\u5728\u5bf9\u7ade\u4e89\u683c\u5c40\u4e86\u89e3\u4e0d\u5168\u9762\u7684\u60c5\u51b5\u4e0b\uff0c\u505a\u51fa\u4ef7\u503c\u6570\u4ebf\u7f8e\u5143\u7684\u51b3\u7b56\u3002\u845b\u5170\u7d20\u53f2\u514b\uff08GSK\uff092025 \u5e74\u4e0e\u6052\u745e\u533b\u836f\u8fbe\u6210\u7684\u534f\u8bae\uff085 \u4ebf\u7f8e\u5143\u9884\u4ed8\u6b3e\uff09\uff0c\u4ee5\u53ca\u53ef\u80fd\u9ad8\u8fbe 125 \u4ebf\u7f8e\u5143\u7684\u91cc\u7a0b\u7891\u603b\u4ef7\u503c\uff0c\u8bf4\u660e\u4e86\u8fd9\u4e9b\u6295\u8d44\u7684\u89c4\u6a21\uff08GSK, 2025\uff09\u3002\u8fd9\u4e9b\u51b3\u7b56\u6240\u4f9d\u8d56\u7684\u7ade\u4e89\u4fe1\u53f7\uff0c\u5b9e\u9645\u4e0a\u51e0\u4e4e\u90fd\u662f\u4e8b\u5148\u53ef\u4ee5\u83b7\u5f97\u7684\u2014\u2014\u5b83\u4eec\u5e76\u975e\u9690\u85cf\u5728\u4e13\u6709\u6570\u636e\u5e93\u6216\u673a\u5bc6\u6587\u4ef6\u4e2d\uff0c\u800c\u662f\u5b58\u5728\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u6ce8\u518c\u5e73\u53f0\u3001\u4e13\u5229\u6570\u636e\u5e93\u3001\u76d1\u7ba1\u5ba1\u8bc4\u8bb0\u5f55\u4ee5\u53ca\u4ea4\u6613\u62ab\u9732\u4e2d\uff0c\u7b49\u5f85\u88ab\u7cfb\u7edf\u6574\u5408\u4e0e\u89e3\u8bfb\u3002<\/p>\n<p>\u80fd\u591f\u6355\u6349\u5230\u8fd9\u4e9b\u4fe1\u53f7\u7684\u7ec4\u7ec7\u4e0e\u9519\u8fc7\u8fd9\u4e9b\u4fe1\u53f7\u7684\u7ec4\u7ec7\u4e4b\u95f4\u7684\u533a\u522b\uff0c\u4e0d\u5728\u4e8e\u4fe1\u606f\u7684\u83b7\u53d6\u6e20\u9053\u3002\u800c\u5728\u4e8e<strong>\u7efc\u5408\u5206\u6790<\/strong>\u3002<\/p>\n<h3>\u7ade\u4e89\u4fe1\u53f7\u7684\u672c\u8d28<\/h3>\n<p>\u771f\u6b63\u7684\u7ade\u4e89\u4fe1\u53f7\u4e0d\u662f\u65b0\u95fb\u7a3f\u3002\u5b83\u662f\u4e00\u79cd\u6a21\u5f0f\u2014\u2014\u4e00\u7cfb\u5217\u53ef\u89c2\u5bdf\u7684\u4e8b\u4ef6\u3002\u7efc\u5408\u89e3\u8bfb\u65f6\uff0c\u80fd\u5728\u610f\u56fe\u6210\u4e3a\u516c\u5f00\u4e8b\u5b9e\u4e4b\u524d\u5c31\u5c06\u5176\u63ed\u793a\u51fa\u6765\u3002\u5728\u751f\u7269\u5236\u836f\u9886\u57df\uff0c\u56db\u79cd\u4fe1\u53f7\u7c7b\u578b\u5177\u6709\u6700\u91cd\u5927\u7684\u6218\u7565\u5f71\u54cd\uff08DrugPatentWatch, 2025\uff09\uff1a<\/p>\n<ul>\n<li><strong>\u7ade\u4e89\u5bf9\u624b\u7684\u7814\u53d1\u7ba1\u7ebf\u52a8\u6001\uff1a<\/strong>\u7ade\u4e89\u5bf9\u624b\u6b63\u5728\u63a8\u8fdb\u7684\u5316\u5408\u7269\u3001\u4e34\u5e8a\u9636\u6bb5\u3001\u76ee\u6807\u9002\u5e94\u75c7\u548c\u4f5c\u7528\u673a\u5236<\/li>\n<li><strong>\u4e13\u5229\u6d3b\u52a8\uff1a<\/strong>\u5e02\u573a\u51c6\u5165\u7684\u77e5\u8bc6\u4ea7\u6743\uff08IP\uff09\u58c1\u5792\uff0c\u4ee5\u53ca\u5fc5\u987b\u8fdb\u884c\u89c4\u907f\u8bbe\u8ba1\u3001\u63d0\u51fa\u8d28\u7591\u6216\u83b7\u5f97\u8bb8\u53ef\u7684\u6743\u5229\u8981\u6c42\u7ed3\u6784<\/li>\n<li><strong>\u76d1\u7ba1\u52a8\u6001\uff1a<\/strong>\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u548c\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\uff08EMA\uff09\u7684\u6307\u5357\u3001\u987e\u95ee\u59d4\u5458\u4f1a\u51b3\u7b56\u3001\u6279\u51c6\u884c\u52a8\u548c\u6267\u6cd5\u6d3b\u52a8<\/li>\n<li><strong>\u4ea4\u6613\u548c\u8bb8\u53ef\u6d3b\u52a8\uff1a<\/strong>\u4ea4\u6613\u65f6\u673a\u3001\u7ed3\u6784\u548c\u4f30\u503c<\/li>\n<\/ul>\n<p>\u6bcf\u4e2a\u9886\u57df\u90fd\u4f1a\u4ea7\u751f\u516c\u5f00\u6570\u636e\u3002\u4fe1\u53f7\u4e0d\u5728\u4e8e\u4efb\u4f55\u5355\u4e00\u6570\u636e\u70b9\uff0c\u800c\u5728\u4e8e\u5b83\u4eec\u7684\u6c47\u5408\u70b9\u3002<\/p>\n<h3>\u5236\u836f\u884c\u4e1a\u7684\u56db\u7c7b\u6838\u5fc3\u7ade\u4e89\u4fe1\u53f7<\/h3>\n<p><strong>\u4fe1\u53f7\u7c7b\u578b 1\uff1a\u7ade\u4e89\u5bf9\u624b\u7684\u7814\u53d1\u7ba1\u7ebf\u52a8\u6001<\/strong><\/p>\n<p>\u7814\u53d1\u7ba1\u7ebf\u52a8\u6001\u662f\u751f\u7269\u5236\u836f\u7ade\u4e89\u60c5\u62a5\uff08CI\uff09\u7684\u57fa\u7840\uff0c\u4f46\u8bb8\u591a\u7ec4\u7ec7\u5728\u5f00\u53d1\u5468\u671f\u4e2d\u7684\u76d1\u6d4b\u4e3a\u65f6\u5df2\u665a\u3002\u53ea\u8ddf\u8e2a 3 \u671f\u8bd5\u9a8c\u7684\u56e2\u961f\uff0c\u662f\u5728\u7ade\u4e89\u5bf9\u624b\u7684\u5173\u952e\u6218\u7565\u51b3\u7b56\u65e9\u5df2\u786e\u5b9a\u4e4b\u540e\u624d\u5f00\u59cb\u89c2\u5bdf\u3002\u800c\u9886\u5148\u7684\u7ec4\u7ec7\u5219\u4f1a\u5bfb\u627e\u65e9\u671f\u7684\u7ade\u4e89\u60c5\u62a5\u4fe1\u53f7\u3002\u4ed6\u4eec\u4f1a\u76d1\u6d4b 1 \u671f\u6ce8\u518c\u3001\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\uff08IND\uff09\u4ee5\u53ca\u5728\u6b63\u5f0f\u6ce8\u518c\u5e93\u66f4\u65b0\u4e4b\u524d\u51fa\u73b0\u7684\u4f1a\u8bae\u6458\u8981\u3002\u5f53\u4e00\u79cd\u5316\u5408\u7269\u8fdb\u5165\u540e\u671f\u8bd5\u9a8c\u65f6\uff0c\u5176\u9002\u5e94\u75c7\u3001\u4f5c\u7528\u673a\u5236\u548c\u60a3\u8005\u4eba\u7fa4\u90fd\u5df2\u786e\u5b9a\u3002\u65e9\u671f\u76d1\u6d4b\u6709\u52a9\u4e8e\u56e2\u961f\u4e86\u89e3\u8d44\u6e90\u96c6\u4e2d\u7684\u65b9\u5411\uff0c\u4ece\u800c\u5b9e\u73b0\u5176\u8d44\u4ea7\u7684\u5dee\u5f02\u5316\u6216\u907f\u514d\u8fdb\u5165\u62e5\u6324\u7684\u6cbb\u7597\u9886\u57df\u3002<\/p>\n<p>\u6309\u9002\u5e94\u75c7\u5bf9\u7ba1\u7ebf\u8fdb\u884c\u805a\u7c7b\u5206\u6790\uff0c\u53ef\u4e3a\u4ea7\u54c1\u7ec4\u5408\u7b56\u7565\u63d0\u4f9b\u6781\u5177\u53ef\u64cd\u4f5c\u6027\u7684\u60c5\u62a5\u3002\u5f53\u591a\u4e2a\u7533\u529e\u65b9\u5728\u540c\u4e00\u9002\u5e94\u75c7\u4e2d\u63a8\u8fdb\u76f8\u4f3c\u7684\u4f5c\u7528\u673a\u5236\u65f6\uff0c\u65e9\u5728\u4efb\u4f55\u5355\u4e2a\u8bd5\u9a8c\u7ed3\u679c\u516c\u5e03\u4e4b\u524d\uff0c\u8fd9\u79cd\u6a21\u5f0f\u5c31\u5df2\u53d8\u5f97\u6e05\u6670\u3002\u5bf9\u4e8e BD \u603b\u76d1\u800c\u8a00\uff0c\u8fd9\u4f1a\u76f4\u63a5\u5f71\u54cd\u8d44\u4ea7\u4f30\u503c\u3002\u4e00\u4e2a\u8fdb\u5165\u5df2\u6709\u4e09\u4e2a 2 \u671f\u7ade\u4e89\u5bf9\u624b\u9886\u57df\u7684\u5316\u5408\u7269\uff0c\u4e0e\u4e00\u4e2a\u8fdb\u5165\u7a7a\u767d\u9886\u57df\u7684\u5316\u5408\u7269\u76f8\u6bd4\uff0c\u5176\u5546\u4e1a\u524d\u666f\u622a\u7136\u4e0d\u540c\u3002\u5bf9\u4e8e R&amp;D \u9886\u5bfc\u8005\u800c\u8a00\uff0c\u8fd9\u4e9b\u6570\u636e\u4f1a\u5f71\u54cd\u8bd5\u9a8c\u8bbe\u8ba1\u3002\u7ec8\u70b9\u9009\u62e9\u3001\u60a3\u8005\u9776\u5411\u548c\u5bf9\u7167\u7ec4\u8bbe\u7f6e\u90fd\u5fc5\u987b\u8003\u8651\u5230\u7ade\u4e89\u5bf9\u624b\u6b63\u5728\u6d4b\u8bd5\u7684\u5185\u5bb9\u3002\u5982\u679c\u591a\u4e2a 3 \u671f\u8bd5\u9a8c\u91c7\u7528\u76f8\u540c\u7684\u4e3b\u8981\u7ec8\u70b9\uff0c\u8be5\u6307\u6807\u5c31\u4f1a\u6210\u4e3a\u76d1\u7ba1\u671f\u671b\u3002<\/p>\n<p><strong>\u4fe1\u53f7\u7c7b\u578b 2\uff1a\u4e13\u5229\u6d3b\u52a8<\/strong><\/p>\n<p>\u5728\u751f\u547d\u79d1\u5b66\u9886\u57df\uff0c\u4e13\u5229\u7533\u8bf7\u662f\u7ade\u4e89\u610f\u56fe\u7684\u6700\u65e9\u6307\u6807\u4e4b\u4e00\u3002\u7136\u800c\uff0c\u8bb8\u591a\u5236\u836f CI \u56e2\u961f\u5ffd\u89c6\u4e86\u4e13\u5229\u7533\u8bf7\uff0c\u5c06 IP \u4e25\u683c\u89c6\u4e3a\u6cd5\u5f8b\u4e8b\u52a1\u800c\u975e\u6218\u7565\u4fe1\u53f7\u3002\u5728\u5927\u591a\u6570\u53f8\u6cd5\u7ba1\u8f96\u533a\uff0c\u4e13\u5229\u7533\u8bf7\u4f1a\u5728\u5176\u4f18\u5148\u6743\u65e5\u540e 18 \u4e2a\u6708\u516c\u5e03,\u56e0\u6b64\u53cd\u6620\u7684\u662f\u7ea6\u4e24\u5e74\u524d\u7684\u7814\u53d1\u51b3\u7b56\u3002\u5c06\u7ade\u4e89\u5bf9\u624b\u7684\u4e13\u5229\u5e03\u5c40\u4e0e\u5176\u4e34\u5e8a\u7ba1\u7ebf\u7ed3\u5408\u5206\u6790\uff0c\u53ef\u4ee5\u63ed\u793a\u4f01\u4e1a\u7684\u5546\u4e1a\u72ec\u5360\u7b56\u7565\u4ee5\u53ca\u5176\u6838\u5fc3\u6280\u672f\u65b9\u5411\u3002\u5f53\u4e00\u5bb6\u516c\u53f8\u5728\u63d0\u4ea4 IND \u7533\u8bf7\u7684\u540c\u65f6\uff0c\u56f4\u7ed5\u7279\u5b9a\u9776\u70b9\u7533\u8bf7\u4e13\u5229\u65f6\uff0c\u8fd9\u4e9b\u7ec4\u5408\u4fe1\u53f7\u8bc1\u5b9e\u4e86\u4e00\u9879\u660e\u786e\u7684\u6218\u7565\u627f\u8bfa\u3002<\/p>\n<p>\u4e13\u5229\u683c\u5c40\u5206\u6790\u7684\u4ef7\u503c\u4e0d\u4ec5\u5e2e\u52a9\u8bc6\u522b\u7ade\u4e89\u5bf9\u624b\u5df2\u5360\u636e\u9886\u57df\uff0c\u4e5f\u63ed\u793a\u5c1a\u672a\u8986\u76d6\u7684\u673a\u4f1a\u7a7a\u95f4\u3002\u7a7a\u767d\u9886\u57df\u5206\u6790 (white space analysis) \u53ef\u4ee5\u627e\u51fa\u90a3\u4e9b\u5728\u6cd5\u5f8b\u4e0a\u5c1a\u4e0d\u62e5\u6324\u3001\u4e14\u5df2\u7ecf\u8fc7\u9a8c\u8bc1\u7684\u751f\u7269\u9776\u70b9\u3001\u60a3\u8005\u4e9a\u7fa4\u548c\u6cbb\u7597\u673a\u5236\u3002\u5bf9\u4e8e\u79ef\u6781\u76d1\u63a7\u8be5\u9886\u57df\u7684\u7ec4\u7ec7\u6765\u8bf4\uff0c\u8fd9\u4e9b\u7a7a\u767d\u63d0\u4f9b\u4e86\u4f18\u5148\u5e03\u5c40\u7684\u77e5\u8bc6\u4ea7\u6743\u673a\u4f1a\u3002\u6b64\u5916\uff0c\u8ddf\u8e2a\u76f8\u5bf9\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u542f\u52a8\u7684\u4e13\u5229\u7533\u8bf7\u8282\u594f\u81f3\u5173\u91cd\u8981\u3002\u8bd5\u9a8c\u6ce8\u518c\u53ef\u4f5c\u4e3a\u73b0\u6709\u6280\u672f\uff0c\u6709\u53ef\u80fd\u4f7f\u5728\u65b9\u6848\u516c\u5f00\u540e\u63d0\u4ea4\u7684\u4e13\u5229\u6743\u5229\u8981\u6c42\u65e0\u6548\u3002\u6574\u5408\u4e13\u5229\u548c\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\uff0c\u53ef\u4e3a\u56e2\u961f\u63d0\u4f9b\u5173\u4e8e\u673a\u4f1a\u548c\u98ce\u9669\u7684\u5168\u9762\u89c6\u56fe\u3002<\/p>\n<p><strong>\u4fe1\u53f7\u7c7b\u578b 3\uff1a\u76d1\u7ba1\u52a8\u6001<\/strong><\/p>\n<p>\u76d1\u7ba1\u4e8b\u4ef6\u63d0\u4f9b\u4e86\u6709\u4ef7\u503c\u7684\u7ade\u4e89\u4fe1\u53f7\uff0c\u4f46\u8bb8\u591a\u56e2\u961f\u4ec5\u5c06\u5176\u89c6\u4e3a\u65b0\u95fb\u66f4\u65b0\uff0c\u800c\u975e\u7ed3\u6784\u6027\u6d1e\u5bdf\u3002\u5f53\u7533\u529e\u65b9\u63d0\u4ea4\u513f\u79d1\u7814\u7a76\u8ba1\u5212\u6216\u83b7\u5f97\u7279\u522b\u65b9\u6848\u8bc4\u4f30\u65f6\uff0c\u5176\u65f6\u673a\u53cd\u6620\u4e86\u4ed6\u4eec\u7684\u76d1\u7ba1\u98ce\u9669\u627f\u53d7\u80fd\u529b\u548c\u5f00\u53d1\u65f6\u95f4\u8868\u3002\u7ade\u4e89\u5bf9\u624b\u7533\u8bf7\u5feb\u901f\u901a\u9053\u8d44\u683c\u6216\u52a0\u901f\u6279\u51c6\uff0c\u8868\u660e\u5176\u5bf9\u672a\u6ee1\u8db3\u7684\u9700\u6c42\u548c\u53ef\u7528\u7684\u66ff\u4ee3\u7ec8\u70b9\u5145\u6ee1\u4fe1\u5fc3\u3002\u8fd9\u4e9b\u76d1\u7ba1\u91cc\u7a0b\u7891\u90fd\u4f1a\u5f71\u54cd\u66f4\u5e7f\u6cdb\u7684\u7ade\u4e89\u683c\u5c40\uff0c\u5e76\u5e2e\u52a9\u7ade\u4e89\u56e2\u961f\u8c03\u6574\u81ea\u5df1\u7684\u4e0a\u5e02\u987a\u5e8f\u3002<\/p>\n<p>\u76d1\u7ba1\u673a\u6784\u7684\u5177\u4f53\u884c\u52a8\u4e3a\u66f4\u5e7f\u9614\u7684\u5e02\u573a\u63d0\u4f9b\u4e86\u9ad8\u5ea6\u9884\u6d4b\u6027\u7684\u89c1\u89e3\u3002\u5f53 FDA \u6216 EMA \u53d1\u5e03\u65b0\u6307\u5357\u65f6\uff0c\u63ed\u793a\u4e86\u5b83\u4eec\u5bf9\u6574\u4e2a\u6cbb\u7597\u7c7b\u522b\u7684\u4e34\u5e8a\u7ec8\u70b9\u3001\u8bd5\u9a8c\u8bbe\u8ba1\u548c\u5b89\u5168\u6027\u6570\u636e\u7684\u4e0d\u65ad\u53d8\u5316\u7684\u671f\u671b\u3002\u987e\u95ee\u59d4\u5458\u4f1a\u7684\u51b3\u7b56\u4e3a\u76d1\u7ba1\u95ee\u9898\u548c\u6295\u7968\u6a21\u5f0f\u63d0\u4f9b\u4e86\u4e00\u4e2a\u516c\u5f00\u9884\u6f14\uff0c\u4f7f\u7ade\u4e89\u5bf9\u624b\u80fd\u591f\u9884\u6d4b\u6f5c\u5728\u7684\u9002\u5e94\u75c7\/\u7528\u6cd5\u9650\u5236\u6216\u4e0a\u5e02\u540e\u8981\u6c42\u3002\u8ddf\u8e2a\u5904\u65b9\u836f\u4f7f\u7528\u8005\u4ed8\u8d39\u6cd5\u6848\uff08PDUFA\uff09\u65e5\u671f\u53ef\u4ee5\u4e3a\u5373\u5c06\u5230\u6765\u7684\u5e02\u573a\u51c6\u5165\u5efa\u7acb\u4e00\u4e2a\u5177\u4f53\u7684\u65f6\u95f4\u8868\uff0c\u5e2e\u52a9\u5546\u4e1a\u56e2\u961f\u51c6\u5907\u5e94\u5bf9\u63aa\u65bd\u3002\u6b64\u5916\uff0c\u76d1\u63a7\u7b2c\u56db\u6bb5\u4e13\u5229\u6311\u6218\u7533\u8bf7\u5bf9\u4e8e\u751f\u547d\u5468\u671f\u7ba1\u7406\u81f3\u5173\u91cd\u8981\u3002\u8fd9\u4e9b\u4e13\u5229\u6311\u6218\u4e3a\u539f\u7814\u836f\u5236\u9020\u5546\u63d0\u4f9b\u4e86\u5173\u4e8e\u5373\u5c06\u53d1\u751f\u7684 IP \u8bc9\u8bbc\u548c\u4eff\u5236\u836f\u5e02\u573a\u51c6\u5165\u7684\u5173\u952e\u9884\u8b66\u3002<\/p>\n<p>\u6301\u7eed\u89e3\u8bfb\u8fd9\u4e9b\u4fe1\u53f7\u80fd\u4e3a\u7ec4\u7ec7\u5e26\u6765\u7ed3\u6784\u6027\u4f18\u52bf\u3002\u56e2\u961f\u65e0\u9700\u7b49\u5f85\u6700\u7ec8\u6279\u51c6\u516c\u544a\uff0c\u5373\u53ef\u9884\u6d4b\u672a\u6765 18 \u81f3 36 \u4e2a\u6708\u7684\u76d1\u7ba1\u8f6c\u53d8\u3002\u8fd9\u79cd\u4e3b\u52a8\u7684\u65b9\u6cd5\u4f7f\u516c\u53f8\u80fd\u591f\u5728\u7ade\u4e89\u5bf9\u624b\u505a\u51fa\u53cd\u5e94\u4e4b\u524d\uff0c\u4ece\u5bb9\u8c03\u6574\u5176\u4e34\u5e8a\u7b56\u7565\u3001\u5b8c\u5584\u652f\u4ed8\u65b9\u6c9f\u901a\u7b56\u7565\u5e76\u8c03\u6574\u5546\u4e1a\u8ba1\u5212\u3002<\/p>\n<p><strong>\u4fe1\u53f7\u7c7b\u578b 4\uff1a\u4ea4\u6613\u548c\u8bb8\u53ef\u6d3b\u52a8\u4fe1\u53f7<\/strong><\/p>\n<p>\u4ea4\u6613\u548c\u8bb8\u53ef\u6d3b\u52a8\u9075\u5faa\u660e\u786e\u6a21\u5f0f\uff0c\u662f\u6781\u5177\u4ef7\u503c\u7684\u7ade\u4e89\u60c5\u62a5\u4fe1\u53f7\u3002\u8ddf\u8e2a\u4ea4\u6613\u65f6\u673a\u3001\u7ed3\u6784\u548c\u4f30\u503c\uff0c\u53ef\u4ee5\u6e05\u6670\u5730\u4e86\u89e3\u7ade\u4e89\u5bf9\u624b\u5982\u4f55\u8bc4\u4f30\u5e02\u573a\u4ee5\u53ca\u4ed6\u4eec\u5728\u4f55\u5904\u5206\u914d\u8d44\u6e90\u3002\u4f8b\u5982\uff0c\u5f53\u4e00\u5bb6\u5927\u578b\u5236\u836f\u516c\u53f8\u5728\u7279\u5b9a\u9002\u5e94\u75c7\u9886\u57df\u8bb8\u53ef\u4e00\u9879\u65e9\u671f\u8d44\u4ea7\u65f6\uff0c\u8fd9\u65e2\u9a8c\u8bc1\u4e86\u8be5\u751f\u7269\u9776\u70b9\uff0c\u4e5f\u51f8\u663e\u4e86\u5176\u6cbb\u7597\u91cd\u70b9\u7684\u8f6c\u53d8\u3002\u6301\u7eed\u76d1\u63a7\u6b64\u7c7b\u4ea4\u6613\u6d3b\u52a8\uff0c\u6709\u52a9\u4e8e BD \u56e2\u961f\u5728\u8fd9\u4e9b\u8d8b\u52bf\u51fa\u73b0\u5728\u66f4\u5e7f\u6cdb\u7684\u5e02\u573a\u62a5\u544a\u4e4b\u524d\uff0c\u5c31\u53d1\u73b0\u54ea\u4e9b\u4f5c\u7528\u673a\u5236\u6b63\u5728\u83b7\u5f97\u7275\u5f15\u529b\uff0c\u4ee5\u53ca\u6295\u8d44\u8d44\u672c\u7684\u6d41\u5411\u3002<\/p>\n<p>\u8fd9\u4e9b\u4ea4\u6613\u7684\u65f6\u673a\u5e38\u5e38\u4e0e\u53ef\u9884\u6d4b\u7684\u4e8b\u4ef6\u76f8\u543b\u5408\uff0c\u4f8b\u5982 2 \u671f\u4e34\u5e8a\u6570\u636e\u516c\u5e03\u6216\u76d1\u7ba1\u63d0\u4ea4\u3002\u8fd9\u4e9b\u91cc\u7a0b\u7891\u4e3a\u4e70\u65b9\u964d\u4f4e\u4e86\u98ce\u9669\uff0c\u5e76\u4e3a\u5356\u65b9\u521b\u9020\u4e86\u660e\u786e\u7684\u4f30\u503c\u62d0\u70b9\u3002\u4e3b\u52a8\u7684\u751f\u7269\u5236\u836f CI \u65b9\u6cd5\u5305\u62ec\u5c06\u7ade\u4e89\u5bf9\u624b\u7684\u4ea4\u6613\u5386\u53f2\u4e0e\u5373\u5c06\u5230\u6765\u7684\u4e34\u5e8a\u65e5\u7a0b\u8fdb\u884c\u6bd4\u5bf9\u3002BD \u56e2\u961f\u65e0\u9700\u7b49\u5f85\u6536\u8d2d\u516c\u544a\u518d\u505a\u51fa\u53cd\u5e94\uff0c\u800c\u53ef\u4ee5\u5728\u91cd\u5927\u6570\u636e\u516c\u5e03\u524d 12 \u81f3 18 \u4e2a\u6708\u5c31\u8bc6\u522b\u51fa\u6f5c\u5728\u7684\u5408\u4f5c\u673a\u4f1a\u3002\u901a\u8fc7\u5c06\u4ea4\u6613\u6a21\u5f0f\u4e0e\u7ba1\u7ebf\u6570\u636e\u548c\u4e13\u5229\u7533\u8bf7\u8fdb\u884c\u4ea4\u53c9\u5f15\u7528\uff0c\u7ec4\u7ec7\u53ef\u4ee5\u5728\u6070\u5f53\u7684\u65f6\u673a\u542f\u52a8\u5408\u4f5c\u5bf9\u8bdd\uff0c\u800c\u4e0d\u662f\u5728\u8d44\u4ea7\u4f30\u503c\u8fbe\u5230\u9876\u5cf0\u540e\u624d\u53bb\u4e89\u593a\u3002<\/p>\n<h3>\u7ade\u4e89\u60c5\u62a5\u7684\u65f6\u6548\u6027\u95ee\u9898<\/h3>\n<p>\u4f20\u7edf\u7ade\u4e89\u60c5\u62a5\u5f80\u5f80\u6ede\u540e\u2014\u2014\u4f01\u4e1a\u5728 3 \u671f\u7ed3\u679c\u53d1\u5e03\u3001\u4ea4\u6613\u5b8c\u6210\u6216\u76d1\u7ba1\u7533\u62a5\u540e\u624d\u5f00\u59cb\u5e94\u5bf9\uff0c\u800c\u8fd9\u4e9b\u4fe1\u606f\u5b9e\u9645\u4e0a\u65e9\u5df2\u5b58\u5728\u3002<\/p>\n<p>\u5373\u4f7f\u5728\u62e5\u6709\u4e13\u95e8\u7ade\u4e89\u60c5\u62a5\u804c\u80fd\u90e8\u95e8\u7684\u5927\u578b\u5236\u836f\u516c\u53f8\uff0c\u60c5\u62a5\u4e5f\u5e38\u5e38\u5728\u9776\u70b9\u9009\u5b9a\u4e4b\u540e\u624d\u59d7\u59d7\u6765\u8fdf\uff0c\u5bfc\u81f4\u5728\u62e5\u6324\u3001\u65e0\u5dee\u5f02\u5316\u7684\u9776\u70b9\u4e0a\u767d\u8d39\u529b\u6c14\uff0c\u6216\u9519\u5931\u7ade\u4e89\u4fe1\u53f7\uff08Angelopoulos, A., 2026\uff09\u3002\u4e00\u5bb6\u5927\u578b\u751f\u7269\u5236\u836f\u516c\u53f8\u5728\u5c06\u7ade\u4e89\u60c5\u62a5\u76f4\u63a5\u6574\u5408\u5230\u5176\u53d1\u73b0\u5de5\u4f5c\u6d41\u7a0b\u540e\uff0c\u5c06\u9776\u70b9\u4f18\u5148\u7ea7\u6392\u5e8f\u65f6\u95f4\u4ece\u56db\u5468\u7f29\u77ed\u81f3\u7ea6\u4e94\u5929\uff08Angelopoulous, A., 2026\uff09\u3002\u5728\u7ade\u4e89\u5bf9\u624b\u4e0d\u65ad\u91c7\u53d6\u6218\u7565\u884c\u52a8\u7684\u683c\u5c40\u4e2d\uff0c\u8fd9\u56db\u5468\u7684\u5ef6\u8fdf\u4e0d\u4ec5\u4ec5\u662f\u4e0d\u4fbf\uff0c\u66f4\u662f\u4e00\u79cd\u4e0d\u65ad\u52a0\u5267\u7684\u4e0d\u5229\u56e0\u7d20\u3002<\/p>\n<p>\u95ee\u9898\u672c\u8d28\u5728\u4e8e\u7ec4\u7ec7\u7ed3\u6784\uff1a\u5546\u4e1a\u3001\u4e34\u5e8a\u4e0e\u76d1\u7ba1\u56e2\u961f\u5404\u81ea\u72ec\u7acb\uff0c\u7f3a\u4e4f\u6574\u5408\u89c6\u89d2\uff0c\u4ece\u800c\u4ea7\u751f\u5173\u952e\u76f2\u70b9\u3002\uff08Pienomial, 2025\uff09\u3002<\/p>\n<h3>\u4e3b\u52a8\u578b CI (Competitive Intelligence)\u80fd\u529b\u7684\u7279\u5f81<\/h3>\n<p>\u91c7\u53d6\u4e3b\u52a8\u60c5\u62a5\u4f53\u7cfb\u7684\u7ec4\u7ec7\u5177\u6709\u4e09\u4e2a\u53ef\u89c2\u5bdf\u7684\u5171\u540c\u7279\u5f81\uff08WNS, 2025; Life Science Dynamics, 2025\uff09\uff1a<\/p>\n<p><strong>\u6301\u7eed\u76d1\u63a7\uff0c\u800c\u975e\u5b9a\u671f\u62a5\u544a\u3002<\/strong> \u60c5\u62a5\u5728\u7ec4\u7ec7\u5404\u804c\u80fd\u90e8\u95e8\u4e4b\u95f4\u6301\u7eed\u6d41\u52a8\uff0c\u800c\u4e0d\u662f\u901a\u8fc7\u5b63\u5ea6\u7b80\u62a5\u6216\u4e34\u65f6\u8bf7\u6c42\u6765\u4f20\u9012\u3002\u5f53\u7ade\u4e89\u5bf9\u624b\u5ba3\u5e03\u7ba1\u7ebf\u66f4\u65b0\u65f6\uff0c\u54cd\u5e94\u662f\u5373\u65f6\u4e14\u7ed3\u5408\u80cc\u666f\u7684\uff0c\u800c\u4e0d\u662f\u63a8\u8fdf\u5230\u4e0b\u4e00\u4e2a\u62a5\u544a\u5468\u671f\u3002\u5f53\u4fe1\u606f\u5728\u5404\u804c\u80fd\u56e2\u961f\u4e4b\u95f4\u6301\u7eed\u6d41\u52a8\u65f6\uff0c\u7ec4\u7ec7\u80fd\u66f4\u5feb\u5730\u505a\u51fa\u66f4\u597d\u7684\u51b3\u7b56\uff0c\u5728\u6570\u5c0f\u65f6\u5185\u800c\u4e0d\u662f\u6570\u5468\u5185\u5bf9\u7ade\u4e89\u4fe1\u53f7\u505a\u51fa\u53cd\u5e94\u3002<br \/>\n<strong>\u8de8\u9886\u57df\u4fe1\u53f7\u6574\u5408\u3002<\/strong> \u7ba1\u7ebf\u6570\u636e\u3001\u4e13\u5229\u7533\u8bf7\u3001\u76d1\u7ba1\u4e8b\u4ef6\u548c\u4ea4\u6613\u62ab\u9732\u4fe1\u606f\u88ab\u76f8\u4e92\u53c2\u7167\u89e3\u8bfb\uff0c\u800c\u4e0d\u662f\u5b64\u7acb\u5730\u8fdb\u884c\u8ddf\u8e2a\u3002\u5f53\u4efb\u4f55\u5355\u4e00\u6570\u636e\u70b9\u88ab\u7f6e\u4e8e\u6765\u81ea\u5176\u4ed6\u9886\u57df\u7684\u540c\u6b65\u4fe1\u53f7\u7684\u80cc\u666f\u4e0b\u65f6\uff0c\u5176\u4ef7\u503c\u5c31\u4f1a\u589e\u52a0\u3002<\/p>\n<p><strong>\u805a\u7126\u65e9\u671f\u9636\u6bb5\u800c\u975e\u540e\u671f\u76d1\u63a7\u3002<\/strong> \u4ece CI \u4e2d\u83b7\u53d6\u6700\u5927\u6218\u7565\u4ef7\u503c\u7684\u7ec4\u7ec7\uff0c\u4e3b\u8981\u5173\u6ce8\u7684\u4e0d\u662f 3 \u671f\u7ade\u4e89\u5bf9\u624b\uff0c\u800c\u662f 1 \u671f\u6ce8\u518c\u3001\u4e34\u5e8a\u524d\u7533\u8bf7\u548c\u53d1\u73b0\u9636\u6bb5\u7684\u4e13\u5229\u6d3b\u52a8\u3002\u66f4\u5e7f\u6cdb\u7684\u65e9\u671f\u8986\u76d6\u8303\u56f4\uff0c\u8de8\u8d8a\u66f4\u591a\u9002\u5e94\u75c7\u548c\u5730\u57df\uff0c\u80fd\u591f\u5728\u7ade\u4e89\u5f62\u52bf\u53d8\u5f97\u96be\u4ee5\u5e94\u5bf9\u4e4b\u524d\u8bc6\u522b\u51fa\u7ade\u4e89\u5bf9\u624b\u7684\u9879\u76ee\uff08Clarivate, 2026a; Clarivate, 2026b\uff09\u3002<\/p>\n<p>\u7406\u60f3\u7684 CI \u4f53\u7cfb\u901a\u8fc7\u5c06\u7ba1\u7ebf\u3001\u4e13\u5229\u3001\u76d1\u7ba1\u3001\u4ea4\u6613\u548c\u5546\u4e1a\u6570\u636e\u6574\u5408\u5230\u5355\u4e00\u8bc1\u636e\u5e93\u4e2d\u6765\u652f\u6301\u8fd9\u79cd\u67b6\u6784\uff0c\u786e\u4fdd\u8de8\u804c\u80fd\u56e2\u961f\u57fa\u4e8e\u4e00\u4e2a\u5171\u4eab\u7684\u3001\u6301\u7eed\u66f4\u65b0\u7684\u60c5\u62a5\u5c42\u5de5\u4f5c\uff0c\u800c\u4e0d\u662f\u5728\u8131\u8282\u7684\u5206\u6790\u5b64\u5c9b\u4e2d\u5de5\u4f5c\u3002<\/p>\n<p>\u76f8\u6bd4\u4e4b\u4e0b\uff0c\u53cd\u5e94\u5f0f\u4f53\u7cfb\u7684\u7279\u70b9\u662f\u6570\u636e\u5b64\u7acb\u3001\u7efc\u5408\u5206\u6790\u5ef6\u8fdf\uff0c\u4ee5\u53ca\u5728\u6218\u7565\u7a97\u53e3\u5173\u95ed\u540e\u624d\u4e3a\u51b3\u7b56\u63d0\u4f9b\u4fe1\u606f\u7684\u60c5\u62a5\u3002\u4e24\u79cd\u60c5\u51b5\u4e0b\u7684\u6570\u636e\u91cf\u662f\u76f8\u540c\u7684,\u4f46\u7ec4\u7ec7\u5bf9\u5176\u91c7\u53d6\u884c\u52a8\u7684\u51c6\u5907\u5ea6\u5374\u4e0d\u540c\uff08MathCo, 2025\uff09\u3002<\/p>\n<h3>\u6570\u636e\u6a21\u5f0f\u63ed\u793a\u4e86\u4ec0\u4e48<\/h3>\n<p>\u5728\u5168\u7403\u5236\u836f\u60c5\u62a5\u5e73\u53f0\u8ffd\u8e2a\u7684\u6570\u4e07\u4e2a\u836f\u7269\u9879\u76ee\u4e2d\u2014\u2014\u6db5\u76d6\u4ece\u53d1\u73b0\u5230\u4e0a\u5e02\u7684\u5168\u8fc7\u7a0b\uff0c\u6d89\u53ca 3,000 \u591a\u79cd\u75be\u75c5\u548c\u6240\u6709\u4e3b\u8981\u5730\u533a\u2014\u2014\u6709\u51e0\u79cd\u53cd\u590d\u51fa\u73b0\u7684\u6a21\u5f0f\uff0c\u53ef\u4ee5\u533a\u5206\u6210\u529f\u9879\u76ee\u548c\u9762\u4e34\u53ef\u9884\u9632\u7684\u7ade\u4e89\u98a0\u8986\u7684\u9879\u76ee\uff08Clarivate, 2026b\uff09\uff1a<\/p>\n<ul>\n<li><strong>\u5728\u80bf\u7624\u5b66\u548c\u514d\u75ab\u5b66\u9886\u57df\uff0c\u9002\u5e94\u75c7\u62e5\u6324\u73b0\u8c61\u52a0\u901f\u6700\u5feb\uff0c<\/strong> \u56e0\u4e3a\u8fd9\u4e9b\u9886\u57df\u7684\u9776\u70b9\u751f\u7269\u5b66\u7279\u5f81\u660e\u786e\uff0c\u591a\u4e2a\u7533\u529e\u65b9\u540c\u65f6\u5bfb\u6c42\u91cd\u53e0\u7684\u4f5c\u7528\u673a\u5236\u3002\u5728\u627f\u8bfa\u8fdb\u884c 2 \u671f\u6295\u8d44\u4e4b\u524d\uff0c\u5bf9\u6574\u4e2a\u9002\u5e94\u75c7\u7684\u7ade\u4e89\u5b9a\u4f4d\u8fdb\u884c\u63cf\u7ed8\u7684\u56e2\u961f\uff0c\u53ef\u4ee5\u907f\u514d\u56f4\u7ed5\u76f8\u540c\u7684\u7ec8\u70b9\u8bbe\u8ba1\u7814\u7a76\u548c\u62db\u52df\u91cd\u53e0\u7684\u60a3\u8005\u4eba\u7fa4\uff08Angelopoulos, A., 2026\uff09\u3002<\/li>\n<li><strong>\u5728\u9776\u70b9\u751f\u7269\u5b66\u5df2\u786e\u7acb\u7684\u6cbb\u7597\u9886\u57df\uff0cIP \u7533\u8bf7\u6d3b\u52a8\u901a\u5e38\u5148\u4e8e\u8bd5\u9a8c\u542f\u52a8\uff0c<\/strong> \u8fd9\u521b\u9020\u4e86\u4e00\u4e2a\u53ef\u68c0\u6d4b\u7684\u4e34\u5e8a\u524d\u4fe1\u53f7\u7a97\u53e3\uff0c\u800c\u4ec5\u9760\u7ba1\u7ebf\u6570\u636e\u5e93\u4f1a\u9519\u8fc7\u8fd9\u4e2a\u7a97\u53e3\uff08Northern Light, 2026\uff09\u3002\u5c06\u4e13\u5229\u7533\u8bf7\u6570\u636e\u4e0e\u7ba1\u7ebf\u8ddf\u8e2a\u76f8\u7ed3\u5408\u53ef\u4ee5\u5f25\u8865\u8fd9\u4e00\u5dee\u8ddd\u3002<\/li>\n<li><strong>\u5728\u76d1\u7ba1\u91cc\u7a0b\u7891\u9644\u8fd1\u5b8c\u6210\u7684\u4ea4\u6613\u4f1a\u83b7\u5f97\u6ea2\u4ef7\u4f30\u503c\uff0c<\/strong> \u4f46\u60c5\u62a5\u4f18\u52bf\u5c5e\u4e8e\u90a3\u4e9b\u5728\u91cc\u7a0b\u7891\u4e8b\u4ef6\u53d1\u751f\u524d\u5f88\u4e45\u5c31\u8bc6\u522b\u51fa\u5177\u5907\u4ea4\u6613\u6761\u4ef6\u7684\u8d44\u4ea7\uff0c\u800c\u4e0d\u662f\u5728 PDUFA \u65e5\u671f\u5f53\u5929\u3002\u7b2c\u56db\u6bb5\u8ba4\u8bc1\u7533\u8bf7\u53ef\u4ee5\u5728\u4efb\u4f55\u4eff\u5236\u836f\u4e0a\u5e02\u524d\u63d0\u4f9b 30 \u4e2a\u6708\u7684\u63d0\u524d\u901a\u77e5\uff0c\u4f46\u8fd9\u4ec5\u9650\u4e8e\u8fd1\u4e4e\u5b9e\u65f6\u76d1\u63a7 FDA \u6570\u636e\u5e93\u7684\u56e2\u961f\uff08DrugPatentWatch, 2025\uff09\u3002<\/li>\n<li><strong>\u5728\u7ed3\u679c\u516c\u5e03\u4e4b\u524d\uff0c\u65b9\u6848\u4fee\u8ba2\u5c31\u5df2\u9884\u793a\u7740\u7ade\u4e89\u538b\u529b\u3002<\/strong> \u5f53\u7533\u529e\u65b9\u5728\u62e5\u6324\u7684\u9002\u5e94\u75c7\u4e2d\u4fee\u6539\u8bd5\u9a8c\u7ec8\u70b9\u65f6\uff0c\u8fdb\u884c\u6301\u7eed\u8bd5\u9a8c\u76d1\u63a7\u7684\u7ade\u4e89\u5bf9\u624b\u53ef\u4ee5\u5728\u4fee\u8ba2\u53d1\u5e03\u5230 ClinicalTrials.gov \u7f51\u7ad9\u540e\u7684\u51e0\u5929\u5185\u89e3\u8bfb\u51fa\u5176\u4e2d\u7684\u7ade\u4e89\u6027\u8be0\u91ca\u2014\u2014\u8fd9\u6bd4\u4efb\u4f55\u6570\u636e\u516c\u5e03\u90fd\u8981\u65e9\u51e0\u4e2a\u6708\uff08DrugPatentWatch, 2025.\uff09\u3002<\/li>\n<\/ul>\n<h3>\u6218\u7565\u9884\u8b66\u7cfb\u7edf<\/h3>\n<p>\u5bf9\u5236\u836f CI \u6700\u6709\u6548\u7684\u91cd\u65b0\u5b9a\u4e49\u4e0d\u662f\u201c\u6211\u4eec\u5bf9\u7ade\u4e89\u5bf9\u624b\u4e86\u89e3\u591a\u5c11\uff1f\u201d\uff0c\u800c\u662f\u201c\u516c\u5f00\u6570\u636e\u4e2d\u7684\u6a21\u5f0f\u63ed\u793a\u4e86\u6211\u4eec\u7684\u7ade\u4e89\u5bf9\u624b\u5c06\u8981\u505a\u4ec0\u4e48\uff1f\u201d<\/p>\n<p>\u8fd9\u79cd\u91cd\u65b0\u5b9a\u4e49\u5bf9 CI \u804c\u80fd\u90e8\u95e8\u7684\u6784\u5efa\u65b9\u5f0f\u5177\u6709\u5b9e\u9645\u5f71\u54cd\u3002\u5b83\u5728\u76d1\u63a7\u9636\u6bb5\u5c06\u6570\u636e\u5e7f\u5ea6\u7f6e\u4e8e\u5206\u6790\u6df1\u5ea6\u4e4b\u4e0a\uff0c\u56e0\u4e3a\u9519\u8fc7\u7684\u4fe1\u53f7\u65e0\u6cd5\u88ab\u5206\u6790\u3002\u5b83\u91cd\u89c6\u8de8\u9886\u57df\u7684\u7efc\u5408\u5206\u6790\uff0c\u800c\u975e\u4efb\u4f55\u5355\u4e00\u9886\u57df\u7684\u4e13\u4e1a\u77e5\u8bc6\uff0c\u56e0\u4e3a\u4e13\u5229\u7533\u8bf7\u3001\u8bd5\u9a8c\u6ce8\u518c\u548c\u4ea4\u6613\u516c\u544a\u7684\u6c47\u5408\u6240\u4f20\u8fbe\u7684\u610f\u4e49\uff0c\u662f\u4e09\u8005\u4e2d\u4efb\u4f55\u4e00\u4e2a\u5355\u72ec\u5b58\u5728\u65f6\u90fd\u65e0\u6cd5\u4f20\u8fbe\u7684\u3002\u800c\u4e14\u5b83\u8981\u6c42\u6301\u7eed\u6d41\u52a8\u800c\u975e\u5b9a\u671f\u4ea4\u4ed8\uff0c\u56e0\u4e3a\u7ade\u4e89\u683c\u5c40\u4e0d\u4f1a\u5728\u62a5\u544a\u5468\u671f\u4e4b\u95f4\u6682\u505c\uff08Evaluate Pharma, 2025\uff09\u3002<\/p>\n<p>\u968f\u7740\u8fdb\u5165\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8d44\u4ea7\u6709 90% \u672a\u80fd\u4e0a\u5e02\uff0c\u4e14\u7814\u53d1\u6210\u672c\u6301\u7eed\u4e0a\u5347\uff0c\u9519\u8fc7\u4e00\u4e2a\u7ade\u4e89\u4fe1\u53f7\u7684\u4ee3\u4ef7\u4e0d\u4ec5\u4ec5\u662f\u9519\u8fc7\u4e00\u4e2a\u89c1\u89e3\uff08Clarivate, 2025; Acta Pharmaceutica Sinica B, 2022\uff09\u3002\u5b83\u53ef\u80fd\u610f\u5473\u7740\u5c06\u6295\u8d44\u6295\u5411\u4e00\u4e2a\u5df2\u7ecf\u9ad8\u5ea6\u62e5\u6324\u7684\u9002\u5e94\u75c7\u9886\u57df\uff0c\u6216\u662f\u5728\u6700\u4f73\u5408\u4f5c\u65f6\u673a\u5df2\u8fc7\u4e4b\u540e\u624d\u542f\u52a8\u5408\u4f5c\u8c08\u5224\uff0c\u4ea6\u6216\u662f\u5728\u7f3a\u4e4f\u5bf9\u7ade\u4e89\u5bf9\u624b\u5e03\u5c40\u53ef\u89c1\u6027\u7684\u60c5\u51b5\u4e0b\u505a\u51fa\u4ea7\u54c1\u7ec4\u5408\u51b3\u7b56\u3002\u80fd\u591f\u907f\u514d\u8fd9\u4e9b\u7ed3\u679c\u7684\u4fe1\u53f7\u5e76\u975e\u4e13\u6709\u4fe1\u606f\uff0c\u5b83\u4eec\u5c31\u5b58\u5728\u4e8e\u516c\u5f00\u4fe1\u606f\u4e4b\u4e2d\u3002<\/p>\n<p><strong>\u7ade\u4e89\u4f18\u52bf\u5c5e\u4e8e\u90a3\u4e9b\u7387\u5148\u8fdb\u884c\u7efc\u5408\u5206\u6790\u7684\u7ec4\u7ec7\u2014\u2014\u4ee5\u53ca\u90a3\u4e9b\u5728\u4fe1\u53f7\u6210\u4e3a\u5934\u6761\u65b0\u95fb\u4e4b\u524d\u5c31\u5df2\u5efa\u7acb\u8d77\u76f8\u5e94\u57fa\u7840\u8bbe\u65bd\u7684\u7ec4\u7ec7\u3002<\/strong><\/p>\n<h3>\u4ece\u4fe1\u53f7\u8bc6\u522b\u5230\u6218\u7565\u884c\u52a8<\/h3>\n<p>\u5c06\u4fe1\u53f7\u610f\u8bc6\u8f6c\u5316\u4e3a\u6218\u7565\u884c\u52a8\uff0c\u9700\u8981\u8d85\u8d8a\u65f6\u70b9\u6027\u7684\u7ade\u4e89\u8bc4\u4f30\uff0c\u8f6c\u5411\u6301\u7eed\u66f4\u65b0\u7684\u60c5\u62a5\u67b6\u6784\u3002\u5bf9\u4e8e CI \u8d1f\u8d23\u4eba\u3001\u4ea7\u54c1\u7ec4\u5408\u7b56\u7565\u5e08\u548c BD \u603b\u76d1\u800c\u8a00\uff0c\u8fd9\u610f\u5473\u7740\uff1a<\/p>\n<ul>\n<li><strong>\u50cf\u76d1\u63a7\u540e\u671f\u6570\u636e\u4e00\u6837\u79ef\u6781\u5730\u76d1\u63a7\u65e9\u671f\u6570\u636e\uff0c<\/strong> \u7279\u522b\u5173\u6ce8\u6b63\u5f0f\u4e34\u5e8a\u6ce8\u518c\u4e4b\u524d\u7684\u53d1\u73b0\u548c\u4e34\u5e8a\u524d\u9879\u76ee\uff08Clarivate, 2026a\uff09<\/li>\n<li><strong>\u5c06\u4e13\u5229\u6570\u636e\u4e0e\u7ba1\u7ebf\u6570\u636e\u7ed3\u5408\uff0c<\/strong>\u4ee5\u68c0\u6d4b\u76f8\u5bf9\u4e8e\u8bd5\u9a8c\u6d3b\u52a8\u7684 IP \u7533\u8bf7\u8282\u594f\uff0c\u7f29\u77ed\u4ece\u7ade\u4e89\u5bf9\u624b\u505a\u51fa R&amp;D \u627f\u8bfa\u5230\u56e2\u961f\u9996\u6b21\u5bdf\u89c9\u4e4b\u95f4\u7684\u65f6\u95f4\u7a97\uff08Northern Light, 2026\uff09<\/li>\n<li><strong>\u81ea\u52a8\u5316\u8ddf\u8e2a FDA\u3001EMA \u548c\u5176\u4ed6\u4e3b\u8981\u76d1\u7ba1\u673a\u6784\u7684\u76d1\u7ba1\u52a8\u6001\uff0c<\/strong>\u4ee5\u5728\u6307\u5bfc\u6027\u6587\u4ef6\u53d1\u5e03\u3001\u987e\u95ee\u59d4\u5458\u4f1a\u51b3\u7b56\u548c\u6279\u51c6\u884c\u52a8\u6210\u4e3a\u5934\u6761\u65b0\u95fb\u4e4b\u524d\u5c31\u6355\u6349\u5230\u8fd9\u4e9b\u91cd\u5851\u7ade\u4e89\u73af\u5883\u7684\u4e8b\u4ef6\uff08DrugPatentWatch, 2025\uff09<\/li>\n<li><strong>\u6839\u636e\u91cc\u7a0b\u7891\u65e5\u7a0b\u5bf9\u4ea4\u6613\u65f6\u673a\u8fdb\u884c\u5efa\u6a21\uff0c<\/strong>\u4ee5\u5728\u8d44\u4ea7\u4f30\u503c\u56e0\u76d1\u7ba1\u98ce\u9669\u964d\u4f4e\u800c\u88ab\u62ac\u9ad8\u4e4b\u524d\uff0c\u786e\u5b9a\u8fdb\u884c BD \u5bf9\u8bdd\u7684\u6700\u4f73\u7a97\u53e3<\/li>\n<li><strong>\u5c06\u6240\u6709\u4fe1\u53f7\u7c7b\u578b\u6c47\u96c6\u5728<\/strong><a href=\"https:\/\/clarivate.com.cn\/life-sciences-healthcare\/portfolio-strategy\/competitive-intelligence\/cortellis-competitive-intelligence-analytics\/\"><strong>Cortellis \u7ade\u4e89\u60c5\u62a5\u6570\u636e\u5e93<\/strong><\/a>\u00a0\u4e2d\uff0c\u800c\u4e0d\u662f\u901a\u8fc7\u9700\u8981\u624b\u52a8\u6838\u5bf9\u7684\u96f6\u6563\u6765\u6e90\u8fdb\u884c\u8ddf\u8e2a\uff08Clarivate, 2026b\uff09<\/li>\n<\/ul>\n<p>\u90a3\u4e9b\u5728\u6cbb\u7597\u9886\u57df\u5904\u4e8e\u9886\u5148\u5730\u4f4d\u7684\u7ec4\u7ec7\uff0c\u5176\u76f4\u89c9\u5e76\u4e0d\u6bd4\u7ade\u4e89\u5bf9\u624b\u66f4\u597d\u3002\u4ed6\u4eec\u62e5\u6709\u66f4\u5f3a\u7684\u6a21\u5f0f\u8bc6\u522b\u80fd\u529b\u2014\u2014\u5e76\u4e14\u4ed6\u4eec\u5df2\u7ecf\u5efa\u7acb\u4e86\u57fa\u7840\u8bbe\u65bd\uff0c\u4ee5\u4fbf\u5728\u8fd9\u4e9b\u6a21\u5f0f\u6210\u4e3a\u516c\u5171\u77e5\u8bc6\u4e4b\u524d\u5c31\u5bf9\u5176\u91c7\u53d6\u884c\u52a8\u3002<\/p>\n<p><strong>\u4fe1\u53f7\u65e9\u5df2\u5b58\u5728\u3002\u6700\u6709\u80fd\u529b\u5bf9\u4fe1\u53f7\u91c7\u53d6\u884c\u52a8\u7684\u7ec4\u7ec7\uff0c\u662f\u90a3\u4e9b\u5df2\u7ecf\u5efa\u7acb\u4e86\u57fa\u7840\u8bbe\u65bd\u6765\u7387\u5148\u53d1\u73b0\u8fd9\u4e9b\u4fe1\u53f7\u7684\u7ec4\u7ec7\u3002<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><em>\u4e86\u89e3\u66f4\u591a\u5173\u4e8e <\/em><strong><em>Cortellis \u7ade\u4e89\u60c5\u62a5\u6570\u636e\u5e93<\/em><\/strong><em>\u5982\u4f55\u5e2e\u52a9\u5236\u836f\u548c\u751f\u7269\u6280\u672f\u56e2\u961f\u4ece\u88ab\u52a8\u8ddf\u8e2a\u8f6c\u5411\u4e3b\u52a8\u6218\u7565\u8fdc\u89c1\uff1a<\/em><a href=\"https:\/\/clarivate.com.cn\/life-sciences-healthcare\/portfolio-strategy\/competitive-intelligence\/cortellis-competitive-intelligence-analytics\/\"><em>Cortellis \u7ade\u4e89\u60c5\u62a5\u6570\u636e\u5e93 | \u79d1\u777f\u552f\u5b89<\/em><\/a><\/p>\n<p>&nbsp;<\/p>\n<h3>\u53c2\u8003\u6587\u732e<\/h3>\n<p>Acta Pharmaceutica Sinica B\uff082022\uff09<em>\u4e3a\u4ec0\u4e48<\/em><em>90%<\/em><em>\u7684\u4e34\u5e8a\u836f\u7269\u5f00\u53d1\u4f1a\u5931\u8d25\u4ee5\u53ca\u5982\u4f55\u6539\u8fdb\uff1f<\/em>2\u6708\u3002\u53ef\u67e5\u9605\uff1a<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9293739\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9293739\/<\/a>\uff08\u8bbf\u95ee\u65e5\u671f\uff1a2026\u5e745\u67088\u65e5\uff09\u3002<\/p>\n<p>Angelopoulos, A.\uff082026\uff09\u2018\u65e9\u671f\u60c5\u62a5\u5982\u4f55\u51b3\u5b9a\u540e\u671f\u6210\u529f\u2019\uff0c<em>Clinical Trial Vanguard<\/em>\uff0c1\u6708\u3002\u53ef\u67e5\u9605\uff1a<a href=\"https:\/\/www.clinicaltrialvanguard.com\/opinion\/how-early-stage-intelligence-determines-late-stage-success\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.clinicaltrialvanguard.com\/opinion\/how-early-stage-intelligence-determines-late-stage-success\/<\/a>\uff08\u8bbf\u95ee\u65e5\u671f\uff1a2026\u5e745\u67088\u65e5\uff09\u3002<\/p>\n<p>Clarivate\uff082025\uff09<em>\u836f\u7269\u65f6\u95f4\u8868\u548c\u6210\u529f\u7387<\/em>\u3002\u53ef\u67e5\u9605\uff1a<a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/lp\/drug-timeline-success-rates\/\" target=\"_blank\" rel=\"noopener\">https:\/\/clarivate.com\/life-sciences-healthcare\/lp\/drug-timeline-success-rates\/<\/a>\uff08\u8bbf\u95ee\u65e5\u671f\uff1a2026\u5e745\u67088\u65e5\uff09\u3002<\/p>\n<p>Clarivate\uff082026a\uff09<em>\u7ade\u4e89\u60c5\u62a5<\/em>\u3002\u53ef\u67e5\u9605\uff1a<a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/portfolio-strategy\/competitive-intelligence\/\" target=\"_blank\" rel=\"noopener\">https:\/\/clarivate.com\/life-sciences-healthcare\/portfolio-strategy\/competitive-intelligence\/<\/a>\uff08\u8bbf\u95ee\u65e5\u671f\uff1a2026\u5e745\u67088\u65e5\uff09\u3002<\/p>\n<p>Clarivate\uff082026b\uff09<em>Cortellis Competitive Intelligence &amp; Analytics<\/em>\u3002\u53ef\u67e5\u9605\uff1a<a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/portfolio-strategy\/competitive-intelligence\/cortellis-competitive-intelligence-analytics\/\" target=\"_blank\" rel=\"noopener\">https:\/\/clarivate.com\/life-sciences-healthcare\/portfolio-strategy\/competitive-intelligence\/cortellis-competitive-intelligence-analytics\/<\/a>\uff08\u8bbf\u95ee\u65e5\u671f\uff1a2026\u5e745\u67088\u65e5\uff09\u3002<\/p>\n<p>DrugPatentWatch\uff082025\uff09<em>\u8f6c\u53d8\u751f\u7269\u5236\u836f\u60c5\u62a5\uff1a\u4ece\u4f20\u7edf\u5206\u6790\u5e08\u8f6c\u5411\u76f4\u63a5\u539f\u59cb\u6570\u636e\u5e73\u53f0<\/em>\u3002\u53ef\u67e5\u9605\uff1a<a href=\"https:\/\/www.drugpatentwatch.com\/blog\/transforming-biopharma-intelligence-moving-from-traditional-analysts-to-direct-raw-data-platforms\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.drugpatentwatch.com\/blog\/transforming-biopharma-intelligence-moving-from-traditional-analysts-to-direct-raw-data-platforms\/<\/a>\uff08\u8bbf\u95ee\u65e5\u671f\uff1a2026\u5e745\u67088\u65e5\uff09\u3002<\/p>\n<p>Evaluate Pharma\uff082025\uff09<em>\u52a0\u5f3a\u751f\u7269\u5236\u836f\u9886\u57df\u7684\u7ade\u4e89\u60c5\u62a5<\/em>\u3002\u53ef\u67e5\u9605\uff1a<a href=\"https:\/\/www.evaluate.com\/blog\/enhancing-competitive-intelligence-in-biopharma\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.evaluate.com\/blog\/enhancing-competitive-intelligence-in-biopharma\/<\/a>\uff08\u8bbf\u95ee\u65e5\u671f\uff1a2026\u5e745\u67088\u65e5\uff09\u3002<\/p>\n<p>GSK\uff082025\uff09<em>GSK<\/em><em>\u4e0e\u6052\u745e\u533b\u836f\u8fbe\u6210\u534f\u8bae\uff0c\u5171\u540c\u5f00\u53d1\u591a\u8fbe<\/em><em>12<\/em><em>\u79cd\u836f\u7269<\/em>\u3002\u65b0\u95fb\u7a3f\uff0c7\u670828\u65e5\u3002\u53ef\u67e5\u9605\uff1a<a href=\"https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/gsk-and-hengrui-pharma-enter-agreements\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/gsk-and-hengrui-pharma-enter-agreements\/<\/a>\uff08\u8bbf\u95ee\u65e5\u671f\uff1a2026\u5e745\u67088\u65e5\uff09\u3002<\/p>\n<p>Life Science Dynamics\uff082025\uff09<em>\u5f53\u4eca\u5236\u836f\u884c\u4e1a\u7ade\u4e89\u60c5\u62a5\u7684\u9a71\u52a8\u529b\u662f\u4ec0\u4e48\uff1f<\/em>\u53ef\u67e5\u9605\uff1a<a href=\"https:\/\/www.lifesciencedynamics.com\/press\/articles\/whats-driving-competitive-intelligence-in-pharma-today\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.lifesciencedynamics.com\/press\/articles\/whats-driving-competitive-intelligence-in-pharma-today\/<\/a>\uff08\u8bbf\u95ee\u65e5\u671f\uff1a2026\u5e745\u67088\u65e5\uff09\u3002<\/p>\n<p>MathCo\uff082025\uff09<em>\u5236\u836f\u7ade\u4e89\u60c5\u62a5\uff1a\u91cd\u8981\u7684\u4fe1\u53f7<\/em>\u3002\u53ef\u67e5\u9605\uff1a<a href=\"https:\/\/mathco.com\/blog\/pharma-competitive-intelligence-signals-that-matter\/\" target=\"_blank\" rel=\"noopener\">https:\/\/mathco.com\/blog\/pharma-competitive-intelligence-signals-that-matter\/<\/a>\uff08\u8bbf\u95ee\u65e5\u671f\uff1a2026\u5e745\u67088\u65e5\uff09\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u7ade\u4e89\u4fe1\u53f7\u662f\u9690\u85cf\u5728\u4e34\u5e8a\u8bd5\u9a8c\u66f4\u65b0\u3001\u4e13\u5229\u7533\u8bf7\u3001\u76d1\u7ba1\u6d3b\u52a8\u548c\u8bb8\u53ef\u4ea4\u6613\u7b49\u516c\u5f00\u6570\u636e\u4e2d\u7684\u65e9\u671f\u7ebf\u7d22\uff0c\u5728\u5e02\u573a\u5b8c\u5168\u53cd\u5e94\u4e4b\u524d\u5c31\u663e\u793a\u51fa\u7ade\u4e89\u5bf9\u624b\u7684\u672a\u6765\u52a8\u5411\u3002\u5728\u5236\u836f\u884c\u4e1a\uff0c\u771f\u6b63\u7684\u6d1e\u5bdf\u529b\u6765\u81ea\u4e8e\u8fde\u63a5\u8fd9\u4e9b\u4fe1\u53f7\uff0c\u56e0\u4e3a\u5355\u4e00\u7684\u7533\u8bf7\u6216\u8bd5\u9a8c\u53d8\u66f4\u7684\u610f\u4e49\u8fdc\u4e0d\u5982\u968f\u65f6\u95f4\u5f62\u6210\u7684\u6a21\u5f0f\u91cd\u8981\u3002<\/p>\n","protected":false},"author":7,"featured_media":241724,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_links_to":"","_links_to_type":0,"footnotes":""},"categories":[3,43],"tags":[],"class_list":["post-436101","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-sciences-healthcare","category-biopharma"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-01 20:50:24","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/436101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/comments?post=436101"}],"version-history":[{"count":8,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/436101\/revisions"}],"predecessor-version":[{"id":436110,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/436101\/revisions\/436110"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/media\/241724"}],"wp:attachment":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=436101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/categories?post=436101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/tags?post=436101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}